Research has stated that most virulent strains of breast cancer can be blocked with small doses of aspirin.
The announcement regarding the painkiller preventing the creation of resistant stem cells that drive breast cancer was welcomed by cancer campaigners. The campaigners added that more research was needed to conclude this.
There were tests carried out on mice and in the laboratory and these tests state that aspirin suppresses the proliferation of breast cancer strains, whether directly or otherwise. This includes the triple negative cancer that leaves women with very few options to resort to.
Tamoxifen was another thing that got a boost with aspirin. Tamoxifen is a treatment that is used often for breast cancer.
Every year in the UK, about 39,000 patients are diagnosed with cancer and Eluned Hughes, of charity Breakthrough Breast Cancer, stated that the treatment was yet to be tested on these patients and urged caution.
She added, "It could be promising for the future. We'll watch this closely to see how it progresses. We hope to continue to see new options for breast cancer patients."
According to a new Wired report, citing a disclosure by Apple, the data which Apple collects for making improvements to its voice-driven Siri service is anonymized, and is kept on the servers of the company for two years before it is discarded....
Austrian authorities have asked Turkey to extradite an Austrian arrested recently. He is wanted...
China-based device manufacturer ZTE has recently revealed that it has worked out a "strategic...
On Friday, Tesla Motors announced a few new perks for customers who own its Tesla Model S electric sedan; and also made some changes to the terms of its service agreement.
Unveiling the new perks for the owners of Model S, Tesla CEO Elon...
Willibald Cernko, the CEO of Bank Austria, said that 2012 was tough year for the banking sector...
Google Street View has recently published digital images of the devastation caused in the...
In a price-hike which took effect in the beginning of 2013, bigwig Israeli drug-manufacturer Teva Pharmaceutical Industries Ltd. increased the costs of Copaxone and Azilect, which are two leading brand drugs of the company.
The increase in...
After having commenced the roll out of the substantially...
The rapidly-growing field of digital assistants for...
Amid the rumors making rounds about the yet-to-be-...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).